The chemokine monocyte chemoattractant protein-1 (MCP-1/CCL2) has been previously shown to be an important mediator of macrophage-related neural damage in models of two distinct inherited neuropathies, Charcot-Marie-Tooth (CMT) 1A and 1B. In mice deficient in the gap junction protein Connexin 32 (Cx32def), an established model for the Xchromosome-linked dominant form of CMT (CMT1X), we investigated the role of the chemokine on macrophage immigration and neural damage by crossbreeding the Cx32def mice with MCP-1 knockout mutants. In Cx32def mutants typically expressing increased levels of MCP-1, macrophage numbers were strongly elevated, caused by an MCP-1-mediated influx of hematogeneous macrophages. Curiously, the complete genetic deletion of MCP-1 did not cause reduced macrophage numbers in the nerves due to compensatory proliferation of resident macrophages. In contrast, and as already seen in other CMT models, heterozygous deletion of MCP-1 led to reduced numbers of phagocytosing macrophages and an alleviation of demyelination. Whereas alleviated demyelination was transient, axonal damage was persistently improved and even robust axonal sprouting at 12 months was detectable. Other axon-related features were alleviated electrophysiological parameters, reduced muscle denervation and atrophy, and increased muscle strength. Similar to models for CMT1A and CMT1B, we identified MEK-ERK signalling as mediating MCP-1 expression in Cx32-deficient Schwann cells. Blocking this pathway by the inhibitor CI-1040 caused reduced MCP-1 expression, attenuation of macrophage increase and amelioration of myelinand axon-related features. Thus, attenuation of MCP-1 upregulation by inhibiting ERK phosphorylation might be a promising approach to treat CMT1X and other so far untreatable inherited peripheral neuropathies in humans.
pathogenic pathway comprising the activation of the MAP-kinases MEK and ERK leading to
Schwann cell borne MCP-1 (CCL2) upregulation, could be identified in the two models (11, 13) .
In the present study, we investigated the pathogenic impact of macrophages and MCP-1 in another model, i. e., in mice being homo-or hemizygously deficient for the X-chromosomerelated gap junction protein Cx32, representing CMT1X neuropathy. We found that -similar to two other CMT models -in Cx32-deficient mice, MCP-1 is upregulated in a MEK-ERKdependent manner. Based on findings in Cx32def mice heterozygously deficient in MCP-1, we found that the chemokine mediates macrophage-related demyelination and, even more strikingly, axon damage that is strongly linked to motor performance. These and our previous data suggest that modulating the activation of macrophages by blocking the MEK-ERK pathway is a promising approach to treat a broad variety of inherited myelin disorders of the CMT1 type.
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Results
MCP-1 is upregulated in myelinating Schwann cells of mice deficient in the X-chromosomerelated gap junction protein Cx32
Immunohistochemistry on teased fiber preparations of six-months-old Cx32-deficient mice (Cx32def) and wild type (wt) littermates revealed MCP-1 immunoreactivity in the mutants, but no or only weak immunoreactivity in the wt mice ( Figure 1A ). Of note, the staining 
, where an approximately six-and three-fold elevation of mRNA was detected at the ages of six and 12 months, respectively (Fig. 1C, D) . Interestingly, at three months of age, qrt-PCR revealed that only hemizygous (male) Cx32def mutants showed a significant MCP-1 upregulation, but not homozygous (female) mutants. This difference was no longer detectable at six months (Fig. 1C) . It is of note that the difference of MCP-1 upregulation between hemizygous male and homozygous female Cx32-null mutants was unexpected, as both genders should behave similar due to the X-chromosomal location of the cx32 gene. This issue will be discussed below.
In order to investigate the impact of MCP-1 on inherited demyelination in the mutants, we cross-bred the Cx32-deficient mutants with MCP-1-deficient mice. Cx32def/MCP-1+/-mutants showed an overall reduction of MCP-1 expression by approximately 50% at six and 6 MCP-1 expression, while MCP-1 mRNA was again not detectable in Cx32wt mice genetically deficient in MCP-1 (Fig. 1D ).
MCP-1 mediates macrophage influx into the peripheral nerve and thereby influences the number of endoneurial macrophages in Cx32def mice
As in other myelin mutant mice, F4/80+ macrophages were substantially and progressively elevated in number in sciatic (not shown) and femoral quadriceps nerves of mice deficient in the X-chromosome-related gap junction protein Cx32 at six and 12 months in comparison to Cx32wt ( Fig. 2A , B, C, D). Interestingly, at three months, only hemizygous (male) Cx32def mutants but not homozygous (female) mutants showed increased numbers of macrophages, reflecting the corresponding MCP-1 elevation in three-months-old male mutants. Again, this difference was no longer detectable at six months (Fig. 2B) .
In Cx32def/MCP-1 double mutants at six months of age, macrophage elevation was significantly lowered when in Cx32def mutants were heterozygous for MCP-1 deficiency, but not in the complete absence of MCP-1 (Fig. 2C) . Similarly, at 12 months of age, heterozygous MCP-1 deficiency still resulted in attenuated macrophage elevation, yet at a lower degree, while homozygous deletion of MCP-1 did not significantly alter macrophage numbers in comparison to Cx32def/MCP-1+/+ (Fig. 2D) .
We also determined the number of macrophages that have phagocytosed myelin as reflected by the foamy appearance using electron microscopy ( Fig. 2 E) . At six months, numbers of foamy macrophages increased to nearly 1 macrophage per 100 myelinated axons in both Cx32def/MCP-1+/+ and Cx32def/MCP-1-/-mutants, whereas Cx32def/MCP-1+/-mutants 7 showed significantly lower numbers of foamy macrophages. At 12 months, Cx32def/MCP-1+/+ and Cx32def/MCP-1+/-mutants showed similar numbers of foamy macrophages, whereas Cx32def/MCP-1-/-mutants showed lower numbers ( Figure 2E ).
In order to investigate whether MCP-1 is involved in the regulation of macrophage influx into mutant nerves, bone marrow from GFP-mutants was transferred to Cx32def/MCP-1 double mutants, enabling to discriminate recently immigrated (green colour) from long-term resident (red colour) intrinsic CD68+ macrophages (Fig. 2G) . Corroborating the results with F4/80+ macrophages, the total number of CD68+ macrophages was generally elevated in the Cx32def mutants. Heterozygous MCP-1 deficiency caused significantly less CD68+ macrophages, with approximately 60% derived from green, immigrating macrophages. When MCP-1 was completely absent, the total number of macrophages was not reduced, but, interestingly, the relationship between intrinsic, non-green macrophages and green, recently immigrated macrophages was inverted, at the expense of the latter. This reflects that MCP-1 is a mediator of macrophage influx into the endoneurium, as has been reported previously in another myelin mutant (12) . It, additionally, suggests the so far not well understood expansion of long-term resident macrophages in Cx32def mutants in the complete absence of MCP-1. As the respective increase of intrinsic macrophages was robust and statistically highly significant (p < 0.01, Fig. 2G ), we investigated by an independent approach whether there is an increased proliferative activity of resident nerve macrophages. By using the proliferation marker Ki67, we could indeed demonstrate that some F4/80+ macrophages are proliferating in the Cx32def/MCP-1-/-mutants, but only very rarely in the Cx32def/MCP-1+/-mice (Suppl. Fig. 8 Since we have previously shown that M-CSF fosters the proliferation of resident macrophages in demyelinating nerves (14, 15) , we investigated whether this cytokine is upregulated in Cx32def/MCP-1-/-mice by qrtPCR. Indeed we could detect a substantially elevated level of M-CSF-specific mRNA in the nerves (Suppl. Fig. 1D ). Moreover, there was no elevated M-CSF level in nerves of Cx32def/MCP-1+/-mice which is in line with the absence of resident macrophage proliferation in these mutants. Thus, the unexpected lack of macrophage decrease in the complete absence of MCP-1 is due to intrinsic macrophage proliferation, most likely caused by a compensatory upregulation of M-CSF.
Transiently improved myelin integrity in Cx32def mutants with heterozygous MCP-1 deficiency
We have previously shown that in two other models for CMT1 disorders, P0+/-and PMP22 overexpressing mice, reduced, but not absent MCP-1 expression led to improved myelin pathology (11, 12) . In the present study, we investigated the same issue by scoring femoral quadriceps nerves of Cx32def/MCP-1+/+, Cx32def/MCP-1+/-and Cx32def/MCP-1-/-mutants in comparison to wild type mice at the age of six and 12 months by electron microscopy. Generally, pathological alterations were always more frequent in Cx32def mice.
Among the myelin mutants, in six-month-old Cx32def/MCP-1+/-mice, abnormally myelinated fibers, comprising thinly and completely demyelinated fibers, were significantly reduced in comparison to Cx32def/MCP-1+/+ and Cx32def/MCP-1-/-mice (Fig. 3A, C) .
Similarly, the number of onion bulbs, supernumerary Schwann cells indicative of demyelination-induced Schwann cell proliferation, was also at lowest level in Cx32def/MCP-1+/-mutants (Fig. 3A, E) . This amelioration of the demyelinating phenotype in Cx32def/MCP-1+/-mutants was only transient, since at 12 months, the pathological features 9 in Cx32def/MCP-1+/+, Cx32def/MCP-1+/-and Cx32def/MCP-1-/-mutants had a comparable degree (Fig. 3B, D, F) . A similar trend of transiently improved myelin integrity in Cx32def/MCP-1+/-mutants was observed in lumbar ventral roots (Suppl. Fig. 2A-D) .
Of note, mutant-specific and immune-independent characteristics of Cx32 deficiency, such as the typical enlarged periaxonal collars (16), were not affected by the different degrees of MCP-1 expression (Suppl. Fig. 3A, B) . Also, abnormal juxtaparanodal aspects with swollen adaxonal Schwann cell profiles (Suppl. Fig. 3C ) and abnormal K+ channel clustering (Suppl. (Fig. 4A, C) . At 12 months, the periaxonal vacuoles were still at lowest level among the Cx32def mutants, although this difference was not as prominent as at six months (Fig. 4B) . Similarly improved axonopathic changes in Cx32def/MCP-1+/-mutants were observed in lumbar ventral roots (Suppl. Fig. 2E, F) . Most interestingly, however, in femoral quadriceps nerves, the amount of regeneration clusters of Cx32def/MCP-1+/-mutants had substantially increased and was significantly higher than in quadriceps 10 nerves of all other Cx32def mutants at 12 months (Fig. 4D) . Moreover, the clusters in We additionally analyzed muscle denervation using immunohistochemistry on whole mount preparations. In Cx32def/MCP-1+/+ and Cx32def/MCP-1-/-mutants we constantly observed individual denervated postsynapses, whereas in Cx32def/MCP-1+/-and Cx32wt mice we rarely found junctions devoid of presynaptic, neurofilament-positive profiles (Fig. 5A ).
As a next step, we performed ATPase cytochemistry at pH 4. 
Heterozygous MCP-1 deficiency in Cx32def mutants improves neurographic properties and increases grip strength
To correlate the reduced axonopathic changes and the occurrence of regeneration clusters with nerve function and motor performance in Cx32def/MCP-1+/-mutants, we performed neurographic recordings and grip strength tests in mutant and wt mice at 9-11 months of age. 
MCP-1 expression in Cx32def Schwann cells is mediated by MEK/ERK MAP-kinase pathway and inhibition of this pathway leads to ameliorated myelin and axon pathology
We have previously shown that in two other myelin mutant mice, P0+/-and PMP22 overexpressing mice, the MEK/ERK MAP-kinase pathway is involved in MCP-1 expression.
We therefore analysed lysates of peripheral nerves from Cx32def mutants by western blot analysis using antibodies to phosphorylated forms of the respective kinases. In quadriceps and sciatic (not shown) nerve lysates from six-months-old mutants, both MEK-and ERKphosphorylation was increased compared to Cx32wt nerve lysates (Fig. 7A ). Interestingly in mutant mice of three months, hemizygous male, but not female mice showed increased phosphorylation of ERK compared to age-and gender-matched Cx32wt mice (Fig. 7B ). This observation strongly correlates with higher MCP-1 mRNA expression and elevated macrophage numbers in young male versus female mutants (see above).
In order to investigate the localization of ERK activation, we performed immunohistochemistry with phospho-specific ERK antibodies on fresh frozen cross-sections ( To proof that MEK-ERK phosphorylation is causally linked to MCP-1 expression, male threemonths-old Cx32 mutant and wt mice were systemically treated with an approved MEKinhibitor (CI-1040) for three weeks at a concentration of 100mg/kg CI-1040 in dimethylsulfoxid. Nerve lysates from verum-treated versus sham-treated Cx32def mutants revealed reduced levels of pERK in western blot analyses (Fig. 8A, B) , confirming the systemic efficacy of the inhibitor. As a major result, impaired ERK-phosphorylation was associated with reduced MCP-1 expression (Fig. 8C) . Strikingly, CI-1040 treatment not only caused reduced MCP-1 expression, but also attenuated increase of endoneurial macrophages in femoral quadriceps nerves (Fig. 8D) . Additionally, we observed reduced amounts of abnormal myelin profiles in lumbar ventral roots (Fig. 8E) after the treatment period of three weeks, being in line with our observations in Cx32def/MCP-1-deficient double mutants.
In order to assess axonal properties we also quantified periaxonal vacuoles in ventral roots and found a tendency towards reduced numbers in verum-treated Cx32def mice compared to sham-treated controls. This difference was not statistically significant, however (Fig. 8F) .
Additionally, we examined axon damage by use of an immunohistochemical marker for low neurofilament phosphorylation (SMI32). We first performed immuno-electron microscopy to confirm specific labelling of abnormal axon profiles using 12 months-old Cx32def nerves.
Some demyelinated axons and axons with vacuoles in Cx32def nerves showed immunopositive low-phosphorylated neurofilament profiles (Suppl. Fig. 5A, B) .
Immunohistochemistry on quadriceps nerves of sham-and verum-treated mutants (Suppl. (18) (19) (20) . We have recently reported that MCP-1 is involved in the development of neuropathic features in two models of CMT1 neuropathies, i.e., in mice heterozygously deficient in the myelin component P0 and in mice mildly overexpressing PMP22, representing CMT1B and CMT1A, respectively, in humans (8, (11) (12) (13) . In the present study we could identify MCP-1 as a potent mediator of peripheral neuropathy in an animal model for CMT1X, a form of demyelinating CMT1-like disorders in which axonal features are most prevalent both in humans and in the corresponding models, as reflected by the occurrence of both impaired axons as well as by abundant regenerative sprouts (3, 17, (21) (22) (23) . Thus, the present model is particularly suitable to investigate the role of MCP-1 with regard to both demyelinating and axonopathic features.
As a first step we investigated the expression of MCP-1 and macrophage numbers in the mutant versus wt mice. Similar to our previous studies in the other models, Schwann cellderived MCP-1 expression and macrophage numbers were substantially increased in peripheral nerves of Cx32def mutants in comparison to wt mice. Additionally, we identified the MAP-kinases MEK and ERK as pathway implicated in MCP-1 elevation, as previously shown for CMT1A and CMT1B models. However, there was an interesting, yet unexpected difference between Cx32def genders in that in homozygous females MEK/ERK activation, MCP-1 elevation and macrophage increase occurred significantly later than in hemizygous male mutants, although the X-chromsomal location of the cx32 gene would predict a similar behaviour of the genders. In this context, it is of note that the female sex hormone progesterone is able to foster the elevation of myelin components (including P0 and PMP22; 15 (24, 25)) and accelerates myelin formation (26). It is, therefore, plausible to assume that in female mutants the naturally higher progesterone levels might lead to an upregulation of transiently compensatory myelin molecules of similar function (e.g., connexin 29; (27-29)) which may lead to a slightly delayed onset of pathology when compared to male mutants. In addition to the robust beneficial effect of random X-activation in heterozygous female CMT-1X patients, our findings identify another mechanism which might contribute to the later onset of disease in female patients and in corresponding mouse models (23) .
In an approach to investigate the principle role of MCP-1 in the mutant mice, we confirmed previous results in another myelin mutant that the chemokine is responsible for immigration of macrophages into the peripheral nerves, using bone marrow chimerism as a tool (12) . 
Materials & Methods
Animals
Cx32-deficient mice (40) were crossbred with MCP-1-deficient mice (11, 41) according to previously published protocols (12, 16 ). Cx32-deficient mice were on a mixed C57BL/6 x 129Sv genetic background, whereas MCP-1 mutants were on a uniform C57BL/6 background. In all experiments littermates were investigated. Determination of genotypes was performed with conventional PCR reaction using isolated DNA from tail biopsies following previously published protocols (12, 16 ). For bone marrow transfer studies, transgenic mice with ubiquitous expression of GFP (42) 
Semiquantitative rt-PCR (qrt-PCR)
Peripheral nerves were dissected, snap frozen in liquid nitrogen and homogenized (ART-MICCRA D-8, ART Labortechnik, Muehlheim, Germany) in TRIZOL reagent (Invitrogen, Karlsruhe, Germany). Total RNA was isolated according to the guidelines of manufacturers.
Concentration and quality of RNA was determined using a BioPhotometer (Eppendorf, Wesseling-Berzdorf, Germany) and 1µg of RNA was reversely transcribed in a 100µl reaction using random hexamer primers (Applied Biosystems, Foster City, CA, USA). cDNA samples were subsequently analyzed as triplicates by qrt-PCR using pre-developed TaqMan assays (Murine MCP-1, 4329581F; Murine M-CSF, Mm00432688_m1; Eukaryotic 18S rRNA Endogenous Control, 4319413E) and TaqMan universal PCR master mix (Applied Biosystems, Foster City, CA, USA) according to the guidelines of manufacturers and previously published protocols (12) .
Immunohistochemistry
Localization of MCP-1 protein was achieved using single fiber preparations of male threeand six-months-old mice as previously described (11) . Specificity of the antibody (rabbit antimouse MCP-1, 4µg/ml, Peprotech, Hamburg, Germany) was controlled by omission of the primary antibody or use of teased fiber preparations from Cx32def/MCP-1-/-mice.
Quantification of endoneurial immune cells was performed on 10µm cross-sections of fresh frozen femoral quadriceps nerves according to previously published protocols (15).
Endoneurial macrophages were detected using rat anti-mouse F4/80 (1:300, Serotec, Eching, Germany) antibodies. Primary rat antibodies were detected by biotinylated goat anti-rat IgG For localization of phosphorylated ERK1/2, teased fiber preparations or 10µm fresh frozen femoral nerve cross sections were stained and evaluated as previously described (13) .
Analysis of muscle innervation was performed using flexor digitorum brevis muscle. After blocking with 5% bovine serum albumin, 10µm thick cross-sections of fresh frozen muscle were incubated with mouse anti-mouse neurofilament 68kDa (1:150, Sigma Aldrich, Taufkirchen, Germany) primary antibodies at 4°C over night, followed by visualization of presynaptic fibers and terminals using Cy3-conjugated donkey anti-mouse IgG secondary antibodies. Postsynapses were stained with Alexa Fluor 488-conjugated α-bungarotoxin (1:400, Molecular Probes, Eugene, OR, USA). In addition, muscles were freshly dissected and squeezed in a drop of 4% paraformaldehyde in PBS between 2 glass slides, postfixed for 15 minutes and whole mount preparations were stained free floating using the same conditions as for muscle cryo-sections except the addition of 0.3% Triton-X to the blocking solution.
Type grouping of muscle fibers in flexor digitorum brevis muscles was visualized by actomyosin ATPase histochemistry at pH 4.3, pH 4.6 and pH 9.4 on muscle cryo-sections as described previously (43) . The distribution of voltage-gated ion channels and integrity of the node of Ranvier was determined as described previously (11) .
Light and fluorescence microscopic images were acquired using an Axiophot 2 microscope (Zeiss, Goettingen, Germany) with an attached CCD camera (Visitron Systems, Tuchheim, Germany) or a confocal microscope (DM RE-7 SDK, Leica, Solms, Germany).
Bone marrow transplantation and identification of endoneurial GFP+/GFP-macrophages
Bone marrow transplantation experiments were performed as previously described (44, 45) . In brief, three-months-old recipient mice were sublethally irradiated with 5 Gy. Bone marrow from adult GFP-transgenic donor mice was isolated and 2 x 10 7 cells were injected into the tail veins of irradiated recipients. Transplanted animals were sacrificed three months later at the age of six months and, in addition to investigating fluorescent leukocytes in blood smears, isolated splenocytes were analyzed by flow cytometry using antibodies against CD4 and CD8
to validate the chimerism. 
Morphometric analysis by electron microscopy
Femoral quadriceps nerves, lumbar ventral roots and flexor digitorum brevis muscles were processed for light and electron microscopy as previously described (15) . Mice at the ages of six and 12 months were transcardially perfused with 4% paraformaldehyde and 2% glutaraldehyde in 0.1M cacodylate buffer. Dissected nerves and muscles were postfixed in the same solution over night at 4°C, followed by osmification, dehydration and embedding in Spurr's medium. Semithin (0.5µm) cross-and longitudinal sections were stained with alkaline methylene blue for light microscopy and ultrathin sections (70nm) were mounted to copper grids and counterstained with lead citrate for electron microscopy. Morphometric analysis was performed with a ProScan Slow Scan CCD (ProScan, Lagerlechfeld, Germany) camera mounted to a Leo 906 E electron microscope (Zeiss, Oberkochen, Germany) and corresponding software iTEM (Soft Imaging System, Muenster, Germany). Multiple image alignments were acquired and characteristic pathological alterations were quantified in relation to the total number of myelin competent axons in whole nerve cross-sections as previously described (16). The number of myelin-competent axons ranged between 450 and 600 for the femoral quadriceps nerves and 750 to 1100 for the lumbar ventral roots with no significant differences related to the genotype.
Immuno-electron microscopy
For immuno-electron microscopy femoral nerves of perfusion fixed mice as described above were embedded in 6% agar after postfixation. 50µm thick vibratome sections were cut and incubated in methanol with 0.3% H 2 O 2. Free-floating sections were blocked with 10% BSA and 1% NGS in PBS and stained with SMI32 antibodies (1:2000; Covance, Muenster, Germany) using the same conditions as for fresh frozen cryo-sections. After diaminobenzidine staining, the sections were osmificated and processed for light and electron microscopy as described.
Neurographic Recordings
9-11 months-old Cx32/MCP-1 double mutants were examined regarding their conduction properties of the sciatic nerves as described previously (11) . Proximal and distal supramaximal stimulation permitted the determination of durations and amplitudes of compound muscle action potentials (CMAP), the latencys of CMAPs and F-wave responses and of nerve conduction velocity.
Determination of grip strength from hind paws
In order to examine the grip strength of Cx32/MCP-1 double mutants in unbiased mixedgender groups at six and 12 months of age, hind limb grip strength tests were performed using an automated grip strength meter (Columbus Instruments, Columbus, OH, USA). Mice were trained to hold the grip bar and were dragged off with constant strength. After two training trials, ten measurements per mouse and day were performed on two consecutive days. The weights of the mice were determined at the first day of testing.
Western blot analyses
Peripheral nerves were quickly dissected, snap frozen in liquid nitrogen and sonicated (Sonoplus HD60, Bandelin electronic, Berlin, Germany) in 100µl lysis buffer (25mM TrisHCl, pH 8, 10mM Hepes, 150mM NaCl, 145mM KCl, 5mM MgCl2, 2mM EDTA, 0.1% SDS, 1% NP-40, 10% Glycerol) per 10mg tissue. Protein concentration was determined by Lowry assay (Sigma Aldrich, Taufkirchen, Germany) and proteins were resolved by SDS-PAGE, transferred to nitrocellulose membranes and visualized using Ponceau S (Roth, Karlsruhe, Germany). Membranes were blocked with skim milk and MEK1/2 and ERK1/2 phosphorylation was detected according to previously published protocols (13) . The resulting signals for phosphorylated kinases were normalized to the amount of the corresponding signal for unphosphorylated kinases following densitometric quantification using ImageJ software (National Institutes of Health, Bethesda, MD, USA).
In Vivo Inhibition of the MEK1/2-Signaling Cascade
To test the functional relevance of the MEK1/2-ERK1/2 cascade in vivo, inhibition studies with the MEK1/2-inhibitor CI-1040 (PD184352) were performed, which was kindly provided by Pfizer (Groton, CT 06340, USA). Three-month-old male Cx32def mice and their wild-type littermates were treated for 21 consecutive days with intraperitoneal injection of either 100mg/kg CI-1040 in dimethylsulfoxid (DMSO; Cx32def: n = 4, wild-type mice n = 2) or DMSO only as a sham control (Cx32def: n = 4, wild-type mice n = 2) as previously described (13) . A maximal injection volume of 50µl was used, and the body weight was monitored daily before injection. After 21 days of treatment, mice were sacrificed and sciatic and femoral nerves were dissected and stored for RNA and protein purification at -80°C or processed for immunohistochemistry against F4/80 and SMI32 as described. Lumbar ventral roots were dissected and postfixed over night in 4% paraformaldehyde and 2% glutaraldehyde in 0.1M cacodylate buffer and processed for electron microscopy as described.
Statistical analysis
All 
